UBS Maintains Buy on Life360, Lowers Price Target to $64

Benzinga Newsdesk www.benzinga.com Negative 64.6%

Neg 64.6% Neu 0% Pos 0%

UBS analyst Stephen Ju maintains Life360 (NASDAQ:LIF) with a Buy and lowers the price target from $75 to $64.

Comments

No comments yet. Be the first!